The Patent Finder
US

Genetic Products Differentially Expressed in Tumors and the Use Thereof

US 9,044,382 In force
OverviewFamilyAssignmentsSources & methods

Term ends Aug 22, 2027 · High confidence

Filed Jan 29, 2007 as application 11/596,649 · Granted Jun 2, 2015
Base term plus 826 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2005 2027
Clock starts
May 18, 2005
Term ends
Aug 22, 2027
Granted
Jun 2, 2015
base term patent term adjustment fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
826
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 826 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 18, 2005, when application PCT/EP2005/005410, the earliest non-provisional in its chain, was filed (this one was filed Jan 29, 2007)May 18, 2025High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+826 days, USPTO patent term adjustment recordAug 22, 2027High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderAug 22, 2027High confidence

This family

US 9,044,382this patent
Aug 2027
Aug 2027
US 9,775,785Term ended
Nov 2023
Nov 2023
Application 15/448,831Abandoned
not computed
not computed
Application 17/079,326Abandoned
not computed
not computed
4 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 25, 2007
Reel 18874, frame 449
Tureci, Ozlem; Sahin, Ugur; Koslowski, MichaelGanymed Pharmaceuticals AGAssignment of Assignor's Interest
Sep 27, 2011
Reel 26974, frame 435
Tureci, Ozlem; Sahin, Ugur; Koslowski, Michael; Fritz, Stefan; Geppert, Harald-gerhardGanymed Pharmaceuticals AGAssignment of Assignor's Interest
Mar 5, 2020
Reel 52032, frame 41
Ganymed Pharmaceuticals GmbHAstellas Pharma Inc.Assignment of Assignor's Interest
Mar 5, 2020
Reel 52114, frame 186
Ganymed Pharmaceuticals AGGanymed Pharmaceuticals GmbHChange of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited